Category: PCI -DES Background: The BioFreedom (BF) biolimus A9 (BA9) coated stent (Biosensors SA, Switzerland) is a new drug-eluting stent (DES) with a 316L stainless steel platform which has been modified with a proprietary surface treatment resulting in a selectively micro-structured abluminal surface. This technology allows adhesion of a potent antiproliferative agent (BA9) to the stent's abluminal surface and further controlled release of the drug without the use of a polymer or binder. We report the first-in-man angiographic outcomes of the BF DES w/ 2 different formulations: standard dose (SD) and low dose (LD).

